Protara Therapeutics Inc. (TARA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Protara Therapeutics Inc.

NASDAQ: TARA · Real-Time Price · USD
4.41
0.16 (3.76%)
At close: Sep 29, 2025, 3:59 PM
4.41
0.00%
After-hours: Sep 29, 2025, 05:18 PM EDT

Protara Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
162.8M 39.59M 24.13M 35.72M
Short-Term Investments
7.49M 25.99M 60.24M 55.51M
Long-Term Investments
n/a n/a 17.89M 39.47M
Other Long-Term Assets
772K 1.03M 1.3M 1.61M
Receivables
n/a 242K 486K 634K
Inventory
n/a n/a 1.16M n/a
Other Current Assets
2K 37K -1.04M 34K
Total Current Assets
172.16M 68.7M 86.15M 93.11M
Property-Plant & Equipment
5.28M 6.56M 7.87M 8.89M
Goodwill & Intangibles
3.25M 2.66M 84K 29.52M
Total Long-Term Assets
9.3M 10.25M 27.14M 79.48M
Total Assets
181.45M 78.95M 113.29M 172.6M
Account Payables
4.43M 2.43M 1.59M 954K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
1.12M n/a n/a 855K
Other Current Liabilities
1.41M 2.11M 2.54M 946K
Total Current Liabilities
10.96M 6.15M 5.74M 4.3M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
3.36M 4.48M 5.47M 6.38M
Total Liabilities
14.32M 10.63M 11.21M 10.68M
Total Debt
4.48M 5.47M 6.38M 7.24M
Book Value
167.13M 68.32M 102.08M 161.91M
Book Value Per Share
8.12 6.03 9.07 14.41
Common Stock
35K 11K 11K 11K
Retained Earnings
-244.98M -200.38M -159.96M -94.01M
Comprehensive Income
2K -31K -688K -211K
Shareholders Equity
167.13M 68.32M 102.08M 161.91M
Total Investments
7.49M 25.99M 78.13M 94.97M